Cita APA (7a ed.)
Sachpekidis, C., Weru, V., Kopp-Schneider, A., Hassel, J. C., & Dimitrakopoulou-Strauss, A. (2023). The prognostic value of [18F]FDG PET/CT based response monitoring in metastatic melanoma patients undergoing immunotherapy: Comparison of different metabolic criteria. European Journal of Nuclear Medicine & Molecular Imaging, 50(9), 2699-2715.
Cita Chicago Style (17a ed.)
Sachpekidis, Christos, Vivienn Weru, Annette Kopp-Schneider, Jessica C. Hassel, y Antonia Dimitrakopoulou-Strauss. "The Prognostic Value of [18F]FDG PET/CT Based Response Monitoring in Metastatic Melanoma Patients Undergoing Immunotherapy: Comparison of Different Metabolic Criteria." European Journal of Nuclear Medicine & Molecular Imaging 50, no. 9 (2023): 2699-2715.
Cita MLA (9a ed.)
Sachpekidis, Christos, et al. "The Prognostic Value of [18F]FDG PET/CT Based Response Monitoring in Metastatic Melanoma Patients Undergoing Immunotherapy: Comparison of Different Metabolic Criteria." European Journal of Nuclear Medicine & Molecular Imaging, vol. 50, no. 9, 2023, pp. 2699-2715.
Precaución: Estas citas no son 100% exactas.